Cargando…
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival Trials
Mid-study design modifications are becoming increasingly accepted in confirmatory clinical trials, so long as appropriate methods are applied such that error rates are controlled. It is therefore unfortunate that the important case of time-to-event endpoints is not easily handled by the standard the...
Autores principales: | Magirr, Dominic, Jaki, Thomas, Koenig, Franz, Posch, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749572/ https://www.ncbi.nlm.nih.gov/pubmed/26863139 http://dx.doi.org/10.1371/journal.pone.0146465 |
Ejemplares similares
-
Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels
por: Żebrowska, Magdalena, et al.
Publicado: (2015) -
Simultaneous confidence intervals that are compatible with closed testing in adaptive designs
por: MAGIRR, D., et al.
Publicado: (2013) -
Estimation after blinded sample size reassessment
por: Posch, Martin, et al.
Publicado: (2016) -
Adaptive two-stage bioequivalence trials with early stopping and sample size re-estimation
por: Koenig, Franz, et al.
Publicado: (2015) -
Treatment selection in multi-arm, multi-stage clinical trials
por: Jaki, Thomas, et al.
Publicado: (2013)